Pharmaceutical Industry News Archive
Get news by email or subscribe to our news feeds.
News Archive for October 2008
October 1, 2008
- Bayer ’s Novel Anticoagulant Xarelto Now Also Approved in the EU
- Florida Attorney General Sues Merck for Misleading State Agencies Over Drug Marketing
October 2, 2008
- Bayer's Novel Oral Anticoagulant Xarelto (Rivaroxaban) Gets European Licence
- Watson Notified of OXYTROL Patent Challenge
- Biotech Holdings Ltd. Announces Strategic Review Process
- New Survey Reveals Consumers Wary of Prescription Switches
- Merck Discontinues Development of Investigational Medicine Taranabant for Obesity
- Physicians Interactive Acquired by Private Investment Firm Perseus L.L.C.
- U.S. Food & Drug Administration Approved the use of REYATAZ (atazanavir sulfate) Boosted with Ritonavir, in Combination Therapy, for Previously Untreated HIV-1 Infected Adult Patients
- PPD Completes Acquisition of InnoPharm
October 3, 2008
- Genentech Issues Dear Healthcare Provider Letter Regarding a Reported Case of PML in a Raptiva Patient
- Cardinal Health Resolves Controlled Substance License Suspensions
- Severe Adverse Event Reported in Raptiva Patient
- Cardinal Health Inc., Agrees to Pay $34 Million to Settle Claims That it Failed to Report Suspicious Sales of Widely-Abused Controlled Substances
- District Court Affirms Patent Infringement Rulings and Finds That Amgen is Entitled to a Permanent Injunction against Roche
October 6, 2008
- Ariad Announces Favorable Ruling Permitting Immediate Appeal of District Court Findings on NF-(kappa)B Patent in Amgen Litigation
- Lilly to Acquire ImClone Systems in $6.5 Billion Transaction
- Waterfront Media To Merge With Revolution Health Network Establishing The Everyday Health Network As The Preeminent Online Health Destination
- Landmark COPD Trial UPLIFT Shows SPIRIVA HandiHaler Sustained Lung Function Improvements Over Four Years
- Westaim enters into reorganization agreement valuing Westaim at $0.60 per share
October 7, 2008
- Anti-Cancer Drug Prevents, Reverses Cardiovascular Damage In Mouse Model Of Premature Aging Disorder
- Eli Lilly and Company Resolves Investigation Involving Numerous States
- AtheroGenics Files for Chapter 11 Bankruptcy
- MedWatch - Tiotropium (Spiriva): updated information on risk of stroke and reports of cardiovascular adverse outcomes
October 8, 2008
- FDA Issues BayerHealthCare Pharmaceuticals, Inc. Warning Letter for Yaz
- Genmab Reports Results of Portfolio Review
October 9, 2008
- EpiCept Receives Ceplene Marketing Approval in Europe
- Novo Nordisk Assigns Inhaled Insulin Patent Portfolio to Aradigm
- Shionogi and Sciele Announce Completion of Subsequent Offering Period
- Nventa Provides Corporate Update and Advancement Plans for HspE7, Hsp 6/11 and Poly-ICR
- Boston Scientific Comments on Involuntary Selling of Its Stock by Co-Founders
- Abbott Opens New Research Facility and Pilot Plant in Ludwigshafen
- Canadian Vaccine Manufacturer Able to Deliver Doses Ahead of Schedule
- AstraZeneca's Purplepill.com Tops the List of Most Visited Pharmaceutical Brand Web Sites in Q2 2008
- Omrix Biopharmaceuticals Provides Update On Fibrin Pad U.S. Phase II Clinical Trial In Mild to Moderate Bleeding
October 10, 2008
- FDA Continues Review of Takeda's New Drug Application for Alogliptin (SYR-322), a DPP-4 Agent for Type 2 Diabetes
- Shionogi Completes Acquisition of Sciele
- Nation's Teen Vaccination Coverage Increasing, But Below 2010 Goals
- FDA Approves AstraZeneca’s Seroquel XR for the Treatment of Bipolar Depression and Bipolar Mania in the US
October 13, 2008
- King Pharmaceuticals Extends Tender Offer to Acquire Alpharma
- AstraZeneca Survey: Physicians Play Critical Role in Helping Patients Take Medicines as Prescribed
- Statins May Prevent Miscarriages
- CSL Receives FTC Request for Additional Information on its Proposed Merger with Talecris Biotherapeutics
October 14, 2008
- Lilly Commences Cash Tender Offer for ImClone Systems at $70 Per Share
- Par Pharmaceutical Announces Resizing of Generic Unit to Optimize Strong First-to-File Pipeline
- Manhattan Research Announces Top Condition Groups Shifting Their TV Viewing Online
- Johnson & Johnson Reports 2008 Third-Quarter Results
October 15, 2008
- Abbott Reports Strong Sales and Earnings Growth in Third Quarter; Again Raises Full-Year Earnings Outlook
- Genentech Announces Third Quarter 2008 Results
- Alcon Announces Two Agreements Designed to Expand Its Future Drug Portfolio
- Emory Creates New Conflict Oversight, Announces New Disclosure Requirements
- Wyeth Provides Regulatory Update Regarding Desvenlafaxine for the Treatment of Major Depressive Disorder
- GSK’s Emerging Markets Strategy Advances With Acquisition in Egypt
- ETHEX Corporation Voluntarily Recalls Three Lots of Dextroamphetamine Sulfate 5mg Tablets Due to the Potential for Oversized Tablets
October 16, 2008
- FDA Grants Full Approval to Ontak (denileukin diftitox) for Use in Patients with Cutaneous T-Cell Lymphoma (CTCL)
- Cell Genesys Announces Termination of VITAL-1 Phase 3 Trial of GVAX Immunotherapy for Prostate Cancer
- Baxter Posts Strong Sales and Earnings for Third Quarter 2008
- Dingell, Stupak Continue DTC Ad Investigation
- Barr Says Court of Appeals Upholds 2005 District Court Decision on 1997 Cipro Settlement
October 17, 2008
- FDA Approves Updated Labeling for Psoriasis Drug Raptiva
- Pfizer Reaches Agreements in Principle to Resolve Litigation Involving Its NSAID Pain Medications
- HHS Preparing to Open FDA Offices in China, India, Europe, and Latin America This Year
- Plaintiffs' Counsel Comments On Settlement in Bextra Marketing, Sales Practices, and Product Liability Litigation
October 20, 2008
- Novartis Delivers Sustained Strong Performance In First Nine Months Of 2008 Underpinned By Accelerating Growth In Pharmaceuticals
- Adventrx Announces Restructuring and Cost Reduction Initiatives
- HLTH Corporation and WebMD Health Corp. Announce Termination of Merger Agreement
- Wisconsin Medical Society Board Passes New Physician Gift Policy
- FDA Issues Draft Guidance on Priority Review Vouchers
October 21, 2008
- Pfizer Reports Third-Quarter 2008 Results
- Biogen Idec Reports Third Quarter 2008 Results
- Schering-Plough Reports Financial Results for Third Quarter of 2008
- Nektar Sells Pulmonary Business to Novartis For $115 Million and Nektar Retains Key Pulmonary Programs Including Amikacin Inhale, Inhaled Vancomycin, and Ciprofloxacin Inhalation Powder
- Myriad Genetics Announces Plan to Separate Into Two Independent Public Companies
- Novartis to Acquire Nektar Therapeutics Pulmonary Business Unit, Strengthening Respiratory Drug Delivery Capabilities
- Forest Laboratories, Inc. Reports Fiscal Second Quarter 2009 Earnings per Share of $0.80
- Kyowa Hakko Kirin Revises Down Profit Forecasts: Full Year Sales Forecast Unchanged
- Trimeris Reports Third Quarter 2008 Fuzoeon Sales Results
- Lilly to Take Charge to Earnings Related to Pending Federal and State Investigations of Past Practices
- Study Documents Safety Problems for Biological Products
October 22, 2008
- Pfizer Names New Head of Clinical Development and Medical Affairs for Its Oncology Business Unit
- Wyeth Reports Earnings Results for the 2008 Third Quarter and First Nine Months
- Merck Reports Third-Quarter 2008 Financial Results
- Dynavax and Merck & Co., Inc. Provide Update on U.S. FDA Clinical Hold on Investigational Vaccine HEPLISAV(TM)
- Everyday Health Network Enters Content Alliance with Yahoo!
- Genzyme Reports Strong Third-Quarter Sales and Earnings Growth
- GSK delivers Q3 business performance EPS of 25.2p and increased dividend of 14p
- Pfizer Completes Settlement Agreements with State Attorneys General Regarding its NSAID Pain Medications
- Better Data Management and More Inspections Are Needed to Strengthen FDA’s Foreign Drug Inspection Program
October 23, 2008
- Alcon's Third Quarter Sales Rise 14.1 Percent
- Lilly Reports Third-Quarter Results
- New Hope for Multiple Sclerosis Sufferers
- Bristol-Myers Squibb Continues Excellent Financial Performance Led By Double-Digit Global Net Sales Growth and Strong Earnings Results
- GlaxoSmithKline and Affiris Sign an Exclusive Licence and Option Agreement for Therapeutic Alzheimer's Disease Candidate Vaccines
- Maxygen Announces Plans to Reduce Spending and Revise Corporate Strategy
- Publicis Healthcare Communications Group (PHCG) Acquires Reed Weir Communications Strengthening its Offering in Australia and APAC
- New President Named at Dorland Global Public Relations
- First Centralised Authorisation To Be Moved To Non-Prescription Status
October 24, 2008
- Further Clinical Trials in Osteoarthritis Pain Suspended for GRC 6211
- To Today's Drug Reps, Docs Just Say No
- Astellas Announces the Withdrawal of EU MAA for Telavancin for Complicated Skin and Soft Tissue Infections
October 27, 2008
- Q3/2008: Merck Total Revenues Increase 8.7% to € 1.9 Billion
- Osteoporosis Drugs Increase Risk for Heart Problems
- Johnson & Johnson Establishes Wellness & Prevention Platform with Acquisition of HealthMedia, Inc.
October 28, 2008
- Meta-Analysis Examines Cardiovascular Effects of Diabetes Medications
- Researchers: Strengthen Restrictions on Off-Label Promotion by Pharmaceutical Companies
- Costlier New Diabetes Drugs Don't Necessarily Produce Better Outcomes, Stanford Researcher Says
- How Drug Companies Covertly Promote Off-Label Drug Use
- Credit Crunch Threatens New Medicines
- First Online Drug Alerts Go to U.S. Doctors
- Harvest Technologies Announces Patient Education Website, www.CLIclinicalstudy.com
October 29, 2008
- FDA Awards NIPTE $1.19 Million Contract to Develop Quality by Design (QbD) Guidance Elements
- Bayer Optimistic About Future Business Trend
- Merck KGaA Announces Collaboration and Licensing Agreement with Theratechnologies for Tesamorelin in the United States
- IMS Health Forecasts 4.5 - 5.5 Percent Growth for Global Pharmaceutical Market in 2009, Exceeding $820 Billion
- Allergan Reports Third Quarter 2008 Operating Results
- Shire's New Product Portfolio Delivers Strong Quarterly Performance
- Growing Number of Consumers Trust Online Resources Over Other Media for Researching Drug Treatment Information – Prospectiv Survey Reveals
October 30, 2008
- GlaxoSmithKline to Acquire Genelabs Technologies to Increase Focus on Novel Small Molecule Therapies for Hepatitis C
- AstraZeneca PLC:Third Quarter and Nine Months Results 2008
- FDA Sends Letter to Amgen Over Sensipar DTC Brochure
- Americans Dissatisfied with Healthcare, Want Lower Costs Even if it Means Sacrificing Quality According to New QualityHealth.com Survey
